Identification |
Name: | 3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE |
Synonyms: | 3,4-DIHYDRO-6-[4-[1-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-TETRAZOL-5-YL]BUTOXY]-2(1H)-QUINOLINONE;OPC-13213(TRANS);4trans-Hydroxy Cilostazol;OPC 13213;trans-3,4-Dihydro-6-[4-[1-(4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone |
CAS: | 87153-04-6 |
Molecular Formula: | C20H27N5O3 |
Molecular Weight: | 385.46 |
InChI: | InChI=1/C20H27N5O3/c26-16-7-5-15(6-8-16)25-19(22-23-24-25)3-1-2-12-28-17-9-10-18-14(13-17)4-11-20(27)21-18/h9-10,13,15-16,26H,1-8,11-12H2,(H,21,27)/t15?,16- |
Molecular Structure: |
|
Properties |
Flash Point: | 383.5°C |
Boiling Point: | 710.5°C at 760 mmHg |
Density: | 1.42g/cm3 |
Refractive index: | 1.691 |
Specification: | White to Off-White Solid usageEng:A metabolite of Cilostazol |
Flash Point: | 383.5°C |
Usage: | A metabolite of Cilostazol |
Safety Data |
|
|